Skip to main content

and
  1. Article

    Open Access

    Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression

    Yangyang Guo, Hengyue Zhu, Yanyi **ao, Hangcheng Guo, Miaomiao Lin in Cell Death & Disease (2022)

  2. Article

    Open Access

    The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression

    Niclosamide, a cell-permeable salicylanilide, was approved by the Food and Drug Administration for its anthelmintic efficiency. A growing body of evidence in recent years suggests that niclosamide exhibits pot...

    Yangyang Guo, Hengyue Zhu, Yanyi **ao, Hangcheng Guo, Miaomiao Lin in Cell Death & Disease (2022)